Business Context and Reporting Period
Company: Molina Healthcare, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 27, 2018 (Reporting event date: June 26, 2018)
Event: Entry into a Material Definitive Agreement for the sale of a subsidiary.
Key Financial Metrics
This filing does not report standard periodic financial metrics such as revenue, profit, cash flow, margins, or debt levels for the reporting period. The primary financial disclosure relates to a specific transaction:
- Transaction Value: Estimated net purchase price of approximately $220 million.
- Asset Sold: 100% of the outstanding equity interests of Molina Information Systems, LLC (doing business as Molina Medicaid Solutions or "MMS").
- Buyer: DXC Technology Company.
- Adjustments: The purchase price is subject to adjustments for working capital, deferred revenue, cash, and debt.
Material Changes
The filing discloses a material change in the Company's corporate structure and operations:
- Divestiture: The Company agreed to sell its wholly-owned subsidiary, MMS, which provides Medicaid solutions.
- Strategic Shift: The transaction represents a strategic move to exit the MMS business line, transferring operations to DXC Technology Company.
Guidance, Outlook, and Risks
Transaction Conditions: The consummation of the sale is subject to customary closing conditions, including:
- Accuracy of representations and warranties.
- Compliance with covenants.
- Receipt of necessary third-party and regulatory consents.
- Expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Clearance).
Financing: The transaction is not subject to any financing condition.
Risks and Contingencies: The agreement includes termination rights for both parties in specified circumstances. The filing explicitly states that representations and warranties in the agreement are for risk allocation between parties and should not be relied upon as factual characterizations of the business without considering other SEC filings.
Investor Verification Checklist
- Verify the final closing date and whether all regulatory consents (including HSR Clearance) have been obtained.
- Confirm the final purchase price after working capital, deferred revenue, cash, and debt adjustments.
- Review Molina Healthcare's subsequent periodic reports (10-Q/10-K) to assess the impact of the MMS divestiture on consolidated revenue and operating margins.
- Check for any updates regarding the integration of MMS into DXC Technology Company's operations.